{
    "clinical_study": {
        "@rank": "166576", 
        "arm_group": [
            {
                "arm_group_label": "Nutrient formulations without active ingredient", 
                "arm_group_type": "Placebo Comparator", 
                "description": "4 nutrient formulations without active ingredient and variable level of available placebo ingredient"
            }, 
            {
                "arm_group_label": "Nutrient formulation with active ingredien", 
                "arm_group_type": "Experimental", 
                "description": "4 nutrient formulations with increasing amount of active ingredient"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess whether food ingredient(s) affect glycemic responses."
        }, 
        "brief_title": "Glycemic Response Testing", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Glycemic Response", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 18-75 years of age\n\n          -  Subject has a body mass index (BMI) \u2265 20.0 and < 35 kg/m\u00b2 at screening (visit 1).\n\n          -  Subject has normal fasting serum glucose (<7.0mmol/L capillary corresponding to whole\n             blood glucose <6.3mmol/L).\n\n          -  Subject has no health conditions that would prevent him from fulfilling the study\n             requirements as judged by the Investigator on the basis of medical history.\n\n          -  Subject understands the study procedures and signs forms providing informed consent\n             to participate in the study and authorization for release of relevant protected\n             health information to the study investigator.\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "38", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020798", 
            "org_study_id": "PEP-1328"
        }, 
        "intervention": {
            "arm_group_label": "Nutrient formulation with active ingredien", 
            "intervention_name": "Dietary Intervention", 
            "intervention_type": "Other"
        }, 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "last_name": "Janice Campbell", 
                "phone": "+1 416-861-0506"
            }, 
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada"
                }
            }, 
            "investigator": {
                "last_name": "Tomas Wolever, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Glycemic response calculated from individual glucose measurements upon consumption of control and experimental test food products. The individual glucose measurements will be collected at baseline (prior to consumption of each test food product) and over a 2-hour period following the initiation of consumption of each test food product. The primary outcome is differential treatment-effect on the time-concentration glucose curve over the 2 hours post consumption of each test food product.", 
            "measure": "Incremental area under the blood glucose response curve", 
            "safety_issue": "No", 
            "time_frame": "0-2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020798"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Rate of decline in blood glucose, peak blood glucose, peak insulin and adjusted time concentration area for insulin", 
            "safety_issue": "No", 
            "time_frame": "0-2 hours"
        }, 
        "source": "PepsiCo Global R&D", 
        "sponsors": {
            "collaborator": {
                "agency": "Glycemic Index Laboratories, Inc", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "PepsiCo Global R&D", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}